Outcomes of Treatment for Melanoma Brain Metastases

Table 2

Systemic treatment after diagnosis of brain metastases.

Type of systemic treatment (1^st line)	Number of patients	Duration of treatment
Chemotherapy
Dacarbazine	5 (31.2%)	2–6 cycles
Temozolomide	3 (18.7%)	1–3 cycles
Carboplatin with paclitaxel	1 (6.2%)	6 cycles
Targeted therapy with vemurafenib ± cobimetinib or dabrafenib ± trametinib	6 (37.5%)	6–16 months
Interferon alfa-2b	1 (6.2%)	6 months